PE20090151A1 - Derivados de pirimidinona y metodos para su uso - Google Patents
Derivados de pirimidinona y metodos para su usoInfo
- Publication number
- PE20090151A1 PE20090151A1 PE2008000681A PE2008000681A PE20090151A1 PE 20090151 A1 PE20090151 A1 PE 20090151A1 PE 2008000681 A PE2008000681 A PE 2008000681A PE 2008000681 A PE2008000681 A PE 2008000681A PE 20090151 A1 PE20090151 A1 PE 20090151A1
- Authority
- PE
- Peru
- Prior art keywords
- fluorophenyl
- cycloalkyl
- aryl
- phenyl
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE A COMPUESTOS DERIVADOS DE PIRIMIDINONA DE FORMULA I, DONDE J Y G SON UN ENLACE SIMPLE, -C(R10)(R11)- O -C(R10)(R11)-C(R10)(R11)-, DE MANERA TAL QUE i)SI J ES -C(R10)(R11)-, ENTONCES G ES -C(R10)(R11)- O -C(R10)(R11)-C(R10)(R11)-, Y ii)SI J ES -C(R10)(R11)-C(R10)(R11)-, ENTONCES G ES UN ENLACE SIMPLE; R ESTA AUSENTE O ES O; R1 ES H, -N(R9)2, -S(O)pR7, -(ALQUILEN)n-CICLOALQUILO, ENTRE OTROS; R2 ES FENILO, 4-FLUOROFENILO, CICLOBUTILO, ENTRE OTROS; R3 ES FENILO, PIRIDILO, 4-FLUOROFENILO, ENTRE OTROS; R4 ES H, 1,2,4-OXADIAZOLILO, HETEROARILO, ENTRE OTROS; R7 ES ALQUILO, ARILO, CICLOALQUILO, ENTRE OTROS; R9, R10 Y R11 SON INDEPENDIENTEMENTE H, ALQUILO, -(ALQUILEN)n-ARILO, ENTRE OTROS; n ES 0 O 1; p ES DE 0 A 2. SON SELECCIONADOS II, III, ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION Y COMPOSICION FARMACEUTICA, QUE PUEDE CONTENER ADICIONALMENTE OTROS PRINCIPIOS ACTIVOS TALES COMO, MEGLITINIDA, SERGLIFLOZINA, LEPTINA, ORLISTAT, SITAGLIPTINA, ENTRE OTROS. DICHOS COMPUESTOS SON MODULADORES DE GPR119, POR LO QUE SON DE UTILIDAD EN EL TRATAMIENTO Y/O PREVENCION DE OBESIDAD, DIABETES, ENFERMEDADES CADIOVASCULARES, ENTRE OTROS
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92545007P | 2007-04-20 | 2007-04-20 | |
US95334207P | 2007-08-01 | 2007-08-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20090151A1 true PE20090151A1 (es) | 2009-02-26 |
Family
ID=39655056
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2008000681A PE20090151A1 (es) | 2007-04-20 | 2008-04-18 | Derivados de pirimidinona y metodos para su uso |
Country Status (11)
Country | Link |
---|---|
US (1) | US20100190687A1 (es) |
EP (1) | EP2148869A1 (es) |
JP (1) | JP2010524940A (es) |
CN (1) | CN102015677A (es) |
AR (1) | AR066121A1 (es) |
CA (1) | CA2684633A1 (es) |
CL (1) | CL2008001126A1 (es) |
MX (1) | MX2009011358A (es) |
PE (1) | PE20090151A1 (es) |
TW (1) | TW200900403A (es) |
WO (1) | WO2008130581A1 (es) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2008038768A1 (ja) * | 2006-09-28 | 2010-01-28 | 大日本住友製薬株式会社 | 二環性ピリミジン構造を有する化合物及びそれを含有する医薬組成物 |
WO2010095767A1 (en) * | 2009-02-23 | 2010-08-26 | Banyu Pharmaceutical Co.,Ltd. | Pyrimidin-4(3h)-one derivatives |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2011113947A1 (en) | 2010-03-18 | 2011-09-22 | Boehringer Ingelheim International Gmbh | Combination of a gpr119 agonist and the dpp-iv inhibitor linagliptin for use in the treatment of diabetes and related conditions |
CN102234287B (zh) | 2010-04-26 | 2015-08-05 | 上海阳帆医药科技有限公司 | 硝基咪唑类化合物、其制备方法和用途 |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
CN102464661B (zh) * | 2010-11-16 | 2015-04-01 | 天津药明康德新药开发有限公司 | 一种5,6,7,8-四氢-咪唑并[1,5-a]吡嗪-1-羧酸乙酯的制备方法 |
CA2836487A1 (en) | 2011-06-09 | 2012-12-13 | Rhizen Pharmaceuticals Sa | Novel compounds as modulators of gpr-119 |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
CN104780915A (zh) | 2012-07-11 | 2015-07-15 | 埃尔舍利克斯治疗公司 | 包含他汀、双胍和用于减小心脏代谢风险的其它药剂的组合物 |
JP6211530B2 (ja) | 2012-11-19 | 2017-10-11 | 武田薬品工業株式会社 | 含窒素複素環化合物 |
JP2016222621A (ja) * | 2015-06-02 | 2016-12-28 | 学校法人九州文化学園 | メラニン合成促進組成物 |
WO2017021805A1 (en) | 2015-07-31 | 2017-02-09 | Pfizer Inc. | 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as magl inhibitors |
RU2720203C1 (ru) | 2017-01-20 | 2020-04-27 | Пфайзер Инк. | 1,1,1-трифтор-3-гидроксипропан-2-илкарбаматные производные как ингибиторы magl |
JP2020506903A (ja) | 2017-01-23 | 2020-03-05 | ファイザー・インク | Magl阻害薬としての複素環式スピロ化合物 |
CN110452157B (zh) * | 2018-12-28 | 2020-11-03 | 广州市朗启医药科技有限责任公司 | 常山酮及其中间体的合成方法 |
CA3132531A1 (en) * | 2019-03-14 | 2020-09-17 | Janssen Sciences Ireland Unlimited Company | Fused ring pyrimidone derivatives for use in the treatment of hbv infection or of hbv-induced diseases |
EP4161643A1 (en) * | 2020-06-05 | 2023-04-12 | Pathios Therapeutics Limited | N-(phenylaminocarbonyl) tetrahydro-isoquinolines and related compounds as modulators of gpr65 |
CA3181982A1 (en) * | 2020-06-09 | 2021-12-16 | David A. Scott | Allosteric egfr inhibitors and methods of use thereof |
WO2022053010A1 (en) * | 2020-09-11 | 2022-03-17 | Janssen Sciences Ireland Unlimited Company | Fused ring pyrimidone derivatives for use in the treatment of hbv infection or of hbv-induced diseases |
WO2022087011A1 (en) * | 2020-10-21 | 2022-04-28 | Aligos Therapeutics, Inc. | Bicyclic compounds |
US11957683B2 (en) | 2021-06-18 | 2024-04-16 | Aligos Therapeutics, Inc. | Bicyclic compounds |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5264439A (en) * | 1990-02-13 | 1993-11-23 | Merck & Co., Inc. | Quinazolinone, triazolinone and pyrimidinone angiotensin II antagonists incorporating a substituted benzyl element |
US5449682A (en) * | 1990-02-13 | 1995-09-12 | Merck & Co., Inc. | Angiotensin II antagonists incorporating a substituted benzyl element |
US5240938A (en) * | 1991-02-13 | 1993-08-31 | Merck & Co., Inc. | Angiotensin II antagonists incorporating a substituted pyridoimidazolyl ring |
US5385894A (en) * | 1991-03-06 | 1995-01-31 | Merck & Co., Inc. | Disubstituted 6-aminoquinazolinones |
US5420133A (en) * | 1993-03-19 | 1995-05-30 | Merck & Co., Inc. | Quinazolinones substituted with phenoxyphenylacetic acid derivatives |
US5401745A (en) * | 1993-03-19 | 1995-03-28 | Merck & Co., Inc. | Quinazolinones substituted with phenoxyphenylacetic acid derivatives |
US5409926A (en) * | 1993-07-19 | 1995-04-25 | Merck & Co., Inc. | AT-2 antagonist inhibition of vascular restenosis |
EP1006113A1 (en) * | 1998-12-02 | 2000-06-07 | Pfizer Products Inc. | Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use to inhibit abnormal cell growth |
ES2280435T3 (es) * | 2000-12-01 | 2007-09-16 | Astellas Pharma Inc. | Metodo de exploracion de remedios para la diabetes. |
JP2006518763A (ja) * | 2003-02-24 | 2006-08-17 | アリーナ ファーマシューティカルズ, インコーポレイテッド | グルコース代謝のモジュレーターとしてのフェニル−およびピリジルピペリジン誘導体 |
EP1951244A4 (en) * | 2005-11-22 | 2010-08-25 | Glaxosmithkline Llc | CALCILYTIC COMPOUNDS |
JPWO2008038768A1 (ja) * | 2006-09-28 | 2010-01-28 | 大日本住友製薬株式会社 | 二環性ピリミジン構造を有する化合物及びそれを含有する医薬組成物 |
-
2008
- 2008-04-17 US US12/596,341 patent/US20100190687A1/en not_active Abandoned
- 2008-04-17 CN CN2008800186357A patent/CN102015677A/zh active Pending
- 2008-04-17 EP EP08742980A patent/EP2148869A1/en not_active Withdrawn
- 2008-04-17 MX MX2009011358A patent/MX2009011358A/es unknown
- 2008-04-17 WO PCT/US2008/004933 patent/WO2008130581A1/en active Application Filing
- 2008-04-17 CA CA002684633A patent/CA2684633A1/en not_active Abandoned
- 2008-04-17 JP JP2010504080A patent/JP2010524940A/ja not_active Withdrawn
- 2008-04-18 TW TW097114371A patent/TW200900403A/zh unknown
- 2008-04-18 PE PE2008000681A patent/PE20090151A1/es not_active Application Discontinuation
- 2008-04-18 CL CL200801126A patent/CL2008001126A1/es unknown
- 2008-04-18 AR ARP080101618A patent/AR066121A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MX2009011358A (es) | 2009-11-05 |
EP2148869A1 (en) | 2010-02-03 |
CL2008001126A1 (es) | 2008-10-24 |
CA2684633A1 (en) | 2008-10-30 |
WO2008130581A1 (en) | 2008-10-30 |
AR066121A1 (es) | 2009-07-22 |
TW200900403A (en) | 2009-01-01 |
US20100190687A1 (en) | 2010-07-29 |
CN102015677A (zh) | 2011-04-13 |
JP2010524940A (ja) | 2010-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20090151A1 (es) | Derivados de pirimidinona y metodos para su uso | |
BRPI0707491B8 (pt) | compostos úteis como agentes moduladores de receptores de mineralocorticóides, os referidos agentes compreendendo os mesmos e composições farmacêuticas | |
BR122012009489B8 (pt) | processo para produzir 2-etóxi-1-{[2-(5-oxo-4,5-diidro-1,2,4-oxadiazol-3-il)bifenil-4-il]metil}-1h-benzimidazol-7-carboxilato de (5-metil-2-oxo-1,3-dioxol-4-il)metila ou um sal do mesmo, composição farmacéutica, e, uso | |
TW200602056A (en) | Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors | |
NO20055688L (no) | Organiske forbindelser | |
TW200738706A (en) | Pyrido-, pyrazo-and pyrimido-pyrimidine derivatives and their use as mTOR inhibitors | |
TW200612936A (en) | Indole derivatives | |
ECSP105253A (es) | Derivados de 5-feniltiazol y uso como inhibidores de pi3 cinasa | |
SE0202133D0 (sv) | Novel compounds | |
GB0305152D0 (en) | Organic compounds | |
TW200833670A (en) | Novel compounds 569 | |
TW200716531A (en) | Cyclohexanesulfonyl derivatives as GLYT1 inhibitors to treat schizophrenia | |
TW200718422A (en) | 1,6-Dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same | |
HUP0302248A2 (hu) | Cianopirrolidin-származékok és az ezeket tartalmazó gyógyászati készítmények | |
BRPI0510666A (pt) | compostos de amida de arila ou heteroarila de metila substituìda, composições farmacêuticas compreendendo os mesmos, uso e combinação | |
TW200626553A (en) | Novel compounds | |
TW200801003A (en) | Novel compounds | |
TW200738666A (en) | Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors | |
ATE360631T1 (de) | Azabicyclische heterocyclen als modulatoren des cannabinoidrezeptors | |
BRPI0519292A2 (pt) | compostos orgÂnicos | |
TW200740781A (en) | Novel compounds | |
TW200510317A (en) | Caspase inhibitors and uses thereof | |
MXPA05010824A (es) | Compuestos biciclicos como antagonistas del receptor nr2b. | |
ATE541839T1 (de) | Pyrrolidiniumderivate als m3-muskarinische rezeptoren | |
SE0303541D0 (sv) | New compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application declared void or lapsed |